Press release
Rising Tobacco Consumption Fuels Growth In The Non-Small Cell Lung Cancer (NSCLC) Market Driver: A Major Catalyst in the Evolution of the Non-Small Cell Lung Cancer (NSCLC) Market in 2025
How Is the Non-Small Cell Lung Cancer (NSCLC) Market Projected to Grow, and What Is Its Market Size?
The non-small cell lung cancer (NSCLC) market has seen rapid growth in recent years. It is projected to increase from $20.1 billion in 2024 to $22.35 billion in 2025, reflecting a CAGR of 11.1%. The historical growth can be linked to advancements in immunotherapy, the adoption of genomic profiling and precision medicine, the expansion of clinical trials, and efforts to reduce smoking rates.
The non-small cell lung cancer (NSCLC) market is expected to grow rapidly, reaching $33.29 billion by 2029 at a CAGR of 10.5%. This growth is driven by emerging combination therapies, AI integration, expansion of personalized vaccines, global research collaborations, and patient-centric care. Key trends include the integration of telemedicine in oncology, the use of liquid biopsy technologies, advances in diagnostic technologies, minimally invasive surgical techniques, and the adoption of immune checkpoint inhibitors.
What Are the Key Drivers Behind the Growth of the Non-Small Cell Lung Cancer (NSCLC) Market?
The growing rate of tobacco consumption is expected to stimulate the expansion of the non-small cell lung cancer (NSCLC) market in the future. Tobacco consumption involves the use of tobacco products through smoking, chewing, or snuffing, introducing nicotine and various harmful chemicals into the body. Tobacco smoke contains carcinogens that can damage lung cell DNA, causing mutations that contribute to the uncontrolled growth of cancerous cells, including NSCLC. For instance, in October 2024, the 2024 National Youth Tobacco Survey, published by the US Food and Drug Administration (USFDA), a US-based federal agency, revealed that 1.1% of all students (approximately 2.25 million) reported using tobacco products, with 10.1% of high school students (about 1.58 million) and 5.4% of middle school students (around 640,000) engaging in tobacco consumption. Furthermore, 2.8% of students (approximately 760,000) reported using combustible tobacco products, while 3.0% (roughly 840,000) admitted to using multiple tobacco products. Consequently, the increasing tobacco consumption rate is driving the growth of the non-small cell lung cancer (NSCLC) market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13232&type=smp
Who Are the Major Industry Players Fueling Non-Small Cell Lung Cancer (NSCLC) Market Expansion?
Major companies operating in the non-small cell lung cancer (NSCLC) market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Clovis Oncology, Revolution Medicines
Which Key Developments Are Influencing the Non-Small Cell Lung Cancer (NSCLC) Market?
Key players in the non-small cell lung cancer (NSCLC) market are developing various treatment strategies, including monotherapy treatments, to gain a competitive advantage. Monotherapy refers to the use of a single drug or therapy to treat a medical condition, rather than a combination of multiple treatments. For instance, in June 2022, Novartis AG, a Switzerland-based pharmaceutical company, received approval from the European Commission (EC), a governing body in Belgium, for Tabrecta (capmatinib) to treat adult patients with advanced non-small cell lung cancer exhibiting METex14 skipping mutations. This approval introduces a novel targeted therapy option for patients in Europe who have previously undergone treatment and have advanced NSCLC with MET exon 14 (METex14) skipping mutations. Tabrecta is a prominent targeted treatment for advanced NSCLC, addressing genetic modifications related to METex14 skipping.
How Is the Segmentation of the Non-Small Cell Lung Cancer (NSCLC) Market Defined?
The non-small cell lung cancer (NSCLC) market covered in this report is segmented -
1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types
2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Squamous Cell Carcinoma
2) By Large Cell Carcinoma: Undifferentiated Large Cell Carcinoma, Large Cell Neuroendocrine Carcinoma
3) By Adenocarcinoma: Invasive Adenocarcinoma, Bronchioloalveolar Carcinoma
4) By Other Types: Mixed Cell Type Carcinoma, Sarcomatoid Carcinoma
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report
What Is the Leading Region in the Non-Small Cell Lung Cancer (NSCLC) Market?
North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (NSCLC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Non-Small Cell Lung Cancer (NSCLC) Global Market Report?
- Market Size Analysis: Analyze the Non-Small Cell Lung Cancer (NSCLC) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Non-Small Cell Lung Cancer (NSCLC) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Non-Small Cell Lung Cancer (NSCLC) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Non-Small Cell Lung Cancer (NSCLC) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13232
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
The non-small cell lung cancer (NSCLC) market has seen rapid growth in recent years. It is projected to increase from $20.1 billion in 2024 to $22.35 billion in 2025, reflecting a CAGR of 11.1%. The historical growth can be linked to advancements in immunotherapy, the adoption of genomic profiling and precision medicine, the expansion of clinical trials, and efforts to reduce smoking rates.
The non-small cell lung cancer (NSCLC) market is expected to grow rapidly, reaching $33.29 billion by 2029 at a CAGR of 10.5%. This growth is driven by emerging combination therapies, AI integration, expansion of personalized vaccines, global research collaborations, and patient-centric care. Key trends include the integration of telemedicine in oncology, the use of liquid biopsy technologies, advances in diagnostic technologies, minimally invasive surgical techniques, and the adoption of immune checkpoint inhibitors.
What Are the Key Drivers Behind the Growth of the Non-Small Cell Lung Cancer (NSCLC) Market?
The growing rate of tobacco consumption is expected to stimulate the expansion of the non-small cell lung cancer (NSCLC) market in the future. Tobacco consumption involves the use of tobacco products through smoking, chewing, or snuffing, introducing nicotine and various harmful chemicals into the body. Tobacco smoke contains carcinogens that can damage lung cell DNA, causing mutations that contribute to the uncontrolled growth of cancerous cells, including NSCLC. For instance, in October 2024, the 2024 National Youth Tobacco Survey, published by the US Food and Drug Administration (USFDA), a US-based federal agency, revealed that 1.1% of all students (approximately 2.25 million) reported using tobacco products, with 10.1% of high school students (about 1.58 million) and 5.4% of middle school students (around 640,000) engaging in tobacco consumption. Furthermore, 2.8% of students (approximately 760,000) reported using combustible tobacco products, while 3.0% (roughly 840,000) admitted to using multiple tobacco products. Consequently, the increasing tobacco consumption rate is driving the growth of the non-small cell lung cancer (NSCLC) market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13232&type=smp
Who Are the Major Industry Players Fueling Non-Small Cell Lung Cancer (NSCLC) Market Expansion?
Major companies operating in the non-small cell lung cancer (NSCLC) market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Clovis Oncology, Revolution Medicines
Which Key Developments Are Influencing the Non-Small Cell Lung Cancer (NSCLC) Market?
Key players in the non-small cell lung cancer (NSCLC) market are developing various treatment strategies, including monotherapy treatments, to gain a competitive advantage. Monotherapy refers to the use of a single drug or therapy to treat a medical condition, rather than a combination of multiple treatments. For instance, in June 2022, Novartis AG, a Switzerland-based pharmaceutical company, received approval from the European Commission (EC), a governing body in Belgium, for Tabrecta (capmatinib) to treat adult patients with advanced non-small cell lung cancer exhibiting METex14 skipping mutations. This approval introduces a novel targeted therapy option for patients in Europe who have previously undergone treatment and have advanced NSCLC with MET exon 14 (METex14) skipping mutations. Tabrecta is a prominent targeted treatment for advanced NSCLC, addressing genetic modifications related to METex14 skipping.
How Is the Segmentation of the Non-Small Cell Lung Cancer (NSCLC) Market Defined?
The non-small cell lung cancer (NSCLC) market covered in this report is segmented -
1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types
2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma, Non-Keratinizing Squamous Cell Carcinoma
2) By Large Cell Carcinoma: Undifferentiated Large Cell Carcinoma, Large Cell Neuroendocrine Carcinoma
3) By Adenocarcinoma: Invasive Adenocarcinoma, Bronchioloalveolar Carcinoma
4) By Other Types: Mixed Cell Type Carcinoma, Sarcomatoid Carcinoma
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report
What Is the Leading Region in the Non-Small Cell Lung Cancer (NSCLC) Market?
North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (NSCLC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Non-Small Cell Lung Cancer (NSCLC) Global Market Report?
- Market Size Analysis: Analyze the Non-Small Cell Lung Cancer (NSCLC) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Non-Small Cell Lung Cancer (NSCLC) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Non-Small Cell Lung Cancer (NSCLC) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Non-Small Cell Lung Cancer (NSCLC) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13232
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
